Govt Planning to amend Schedule V of D&C Rules 1945 for regulation of vitamins.This is following the Drugs Technical Advisory Board (DTAB) having recently examined the Indian Council of Medical
Ban on Methylcobalamin to be revoked soon, echoes eminent consultant,Dr Sanjay Agrawal. Dr Sanjay Agrawal has stated that ‘the blanket ban on methylcobalamin would soon be revoked,as it has been approved
THE ROLE OF NUTRACEUTICALS IN PANDEMIC The impending pandemic today has created a panic situation throughout the world. This emergency situation has created an eye opening in the people
Lincoln Pharmaceuticals to expand export network to 90 plus countries post EU approval; Becomes a Zero net-debt company. It reports a 16.70% rise in the Standalone Net Profit at Rs. 35.19
Industry at crossroads as health ministry misguided on putting in place right regulatory regime to control nutraceuticals and drugs. FSSAI and CDSCO have been drawing flak from the industry as
Corona disease has brought in challenges, at individual level and society at large. More than ever before, clinical trial has generated a lot of interest during the times of Covid-19.
FSSAI red faced as Industry lambasts authority for denigrating science by subscribing to ICMR arbitrary RDA values. There is an urgent need for inclusion of methylcobalamin in the gazette and
Vitamin-C tablets market in India should be seen through the patient lens. There has been a steep rise in the cost of raw materials used to manufacture this immunity boosting
Double Standards of FSSAI exposed due to arbitrary RDA Value of Methylcobalamin, which is a great influencing and active form of vitamin B12. It is also known as mecobalamin or
